NeuroOne Medical Technologies Dividends and Buybacks
Dividend criteria checks 0/6
NeuroOne Medical Technologies does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-17.4%
Buyback Yield
| Total Shareholder Yield | -17.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead
Dec 10Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Dec 16
Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?
Jul 25Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
Apr 11We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully
Sep 15NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
Aug 03Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Jun 02Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky
Dec 18NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
Nov 19Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?
Sep 04We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate
May 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NMTC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NMTC's dividend payments have been increasing.
Dividend Yield vs Market
| NeuroOne Medical Technologies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NMTC) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.6% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast (NMTC) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate NMTC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NMTC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NMTC's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NMTC has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 14:57 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuroOne Medical Technologies Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Alexander Nowak | Craig-Hallum Capital Group LLC |